arrow_back Back to App

Better Care for PFAS Patients: New Medical Guidelines

This act aims to improve healthcare for individuals affected by PFAS substances, commonly known as "forever chemicals." It will provide citizens with access to up-to-date information and medical recommendations on the health effects of these substances, helping doctors better diagnose and treat patients. The act ensures regular updates to these guidelines, keeping care aligned with the latest scientific knowledge.
Key points
Regular assessments of PFAS health effects: Experts will study how PFAS substances measured in human tissues impact health.
New recommendations for doctors: Based on these studies, up-to-date guidelines will be developed to help doctors treat patients with PFAS-related health issues.
Public access to information: Guidelines will be available online and disseminated to health authorities, ensuring everyone can benefit.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_6674
Sponsor: Rep. Kildee, Daniel T. [D-MI-8]
Process start date: 2023-12-07
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Better Care for PFAS Patients Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_6674.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-12-07.

What are the main provisions?

Key points include:

  • Regular assessments of PFAS health effects: Experts will study how PFAS substances measured in human tissues impact health.
  • New recommendations for doctors: Based on these studies, up-to-date guidelines will be developed to help doctors treat patients with PFAS-related health issues.
  • Public access to information: Guidelines will be available online and disseminated to health authorities, ensuring everyone can benefit.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Kildee, Daniel T. [D-MI-8].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Environment, Manufacturing, and Critical Materials.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health Environment